Person:
GÜRSES, HÜLYA NILGÜN

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır.
Organizational Units
Job Title
First Name
HÜLYA NILGÜN
Last Name
GÜRSES
Name
Email Address
Birth Date

Search Results

Now showing 1 - 7 of 7
  • PublicationMetadata only
    Fizyoterapi Rehabilitasyon Mesleğinin Tarihçesi
    (Nobel Tıp Kitapevi, 2021-12-01) Gürses H. N.; GÜRSES, HÜLYA NILGÜN
  • PublicationOpen Access
    Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: A randomised controlled trial
    (2019-03-01) Zeren, MELİH; Cakir, ERKAN; Gurses, HÜLYA NİLGÜN; ZEREN, MELIH; ÇAKIR, ERKAN; GÜRSES, HÜLYA NILGÜN
    Background: Previous research has found conflictive results regarding the benefits of inspiratory muscle training (IMT) for cystic fibrosis (CF) patients. Also, involvement of postural stability is a rising concern in chronic lung diseases but its role in CF patients is poorly understood. Our aim was to investigate the effects of IMT in CF patients as well as analysing the factors which may be related to postural stability.
  • PublicationMetadata only
    Do handgrip strength and dexterity predict respiratory function in neuromuscular disease?
    (2022-11-01) Safran E.; Ozer A. Y.; Gurses H. N.; GÜRSES, HÜLYA NILGÜN
    Background: Neuromuscular diseases are acquired or inherited diseases that affect the function of the muscles in our body, including respiratory muscles. Objective: We aimed to discover more cost-effective and practical tools to predict respiratory function status, which causes serious problems with patients with neuromuscular disease. Methods: The Vignos and Brooke Upper Extremity Functional Scales were used to evaluate functional status for patient recruitment. The handgrip strength and dexterity of patients were measured using a dynamometer and nine-hole peg test. Respiratory function parameters: forced vital capacity, forced expiratory volume in one second, and peak expiratory flow were evaluated using spirometry. Results: The mean age of the 30 patients was 11.5 ± 3.79 years old. Significant relationships were found between nine-hole-peg-test scores and respiratory function parameters on both sides. Significant correlations were found between both handgrip strength and respiratory function parameters (p < 0.05). In the linear regression analysis, it was seen that the forced expiratory volume in 1 second, and peak expiratory flow values could be explained in different percentages (p < 0.05). Conclusions: Handgrip strength and dexterity measurements can be used as indicators for estimating respiratory function parameters in terms of cost and accessibility, although it is known that they will not replace respiratory function tests.
  • PublicationMetadata only
    Pes Planusu Olan Genç Erı̇şkı̇nlerde Statı̇k ve Dı̇namı̇k Dengenı̇n Değerlendı̇rı̇lmesı
    (2022-12-30) Tuncer D.; Gürses H. N.; TUNCER, DENİZ; GÜRSES, HÜLYA NILGÜN
  • PublicationOpen Access
    Cut-off values of 6-min walk test and sit-to-stand test for determining symptom burden in atrial fibrillation
    (2022-01-01T00:00:00Z) Zeren, Melih; Karci, Makbule; DEMİR, Rengin; GÜRSES, Hülya Nilgün; OKTAY, Veysel; UZUNHASAN, Işıl; YİĞİT, Zerrin; GÜRSES, HÜLYA NILGÜN
    Background Since symptomatology is a major predictor of quality of life and an endpoint for the management of atrial fbrillation (AF), practical approaches for objectively interpreting symptom burden and functional impairment are needed. Aims We aimed to provide cut-of values for two frequently used feld tests to be able to objectively interpret symptom burden in atrial fbrillation. Methods One hundred twenty-fve patients with AF were evaluated with European Heart Rhythm Association (EHRA) score, 6-min walk test (6MWT), 30 s sit-to-stand test (30 s-STST), Short-Form 36 (SF-36), International Physical Activity Questionnaire-Short Form (IPAQ-SF), and spirometry. Patients with EHRA 1 were classifed as “asymptomatic”, and those with EHRA 2–4 as “symptomatic”. Cut-of values of 6MWT and 30 s-STST for discriminating between these patients were calculated. Results The optimal cut-of value was “450 m” for 6MWT (sensitivity: 0.71; specifcity of 0.79) and “11 repetitions” for 30 s-STST (sensitivity 0.77; specifcity of 0.70). Area under ROC curve was 0.75 for both tests (p<0.001). Subgroup analysis revealed patients below cut-of values also had worse outcomes in SF-36, IPAQ-SF, and spirometry. Conclusions In patients with AF, walking < 450 m in 6MWT or performing < 11 repetitions in 30 s-STST indicates increased symptom burden, as well as impaired exercise capacity, quality of life, physical activity participation, and pulmonary function. These cut-of values may help identifying patients who may require adjustments in their routine treatment or who may beneft from additional rehabilitative approaches.
  • PublicationOpen Access
    Relationship of respiratory muscle strength, pulmonary function, and functional capacity with quality of life in patients with atrial fibrillation.
    (2018-01-01) DEMIR, R; Zeren, MELİH; Gurses, HÜLYA NİLGÜN; YIGIT, Z; ZEREN, MELIH; GÜRSES, HÜLYA NILGÜN
    Objective: To examine the relationship of pulmonary parameters and functional capacity with quality of life (QoL) in patients with atrial fibrillation (AF). Methods: Thirty-six patients with chronic AF were included in this cross-sectional study. QoL was assessed with the Medical Outcomes Survey 36-item Short Form (SF-36) and Minnesota Living with Heart Failure Questionnaire (MLHFQ). Respiratory muscle strength and pulmonary function were also measured. Functional capacity was assessed with the 6-min walk test (6MWT). The Borg CR10 Scale was used to determine the resting dyspnea and fatigue levels. Results: The SF-36 physical component summary score was correlated with the maximum inspiratory pressure (r ¼ 0.517), maximum expiratory pressure (r ¼ 0.391), 6MWT distance (r ¼ 0.542), resting Borg dyspnea score (r ¼ 0.692), and resting Borg fatigue score (r ¼ 0.727). The MLHFQ total score was correlated with the maximum inspiratory pressure (r ¼ 0.542), maximum expiratory pressure (r ¼ 0.384), 6MWT distance (r ¼ 0.535), resting Borg dyspnea score (r ¼ 0.641), and resting Borg fatigue score (r ¼ 0.703). The resting Borg fatigue score was the significant independent predictor of the SF-36 physical component score and the MLHFQ total score. Conclusion: Respiratory muscle strength, functional capacity measured with the 6MWT, and resting symptoms including dyspnea and fatigue may have an impact on QoL in patients with AF.
  • PublicationMetadata only
    The effect of incentive spirometry in addition to comprehensive chest physiotherapy on length of hospital stay and hemodynamic responses in patients with COPD exacerbation
    (2023-09-01) Kulli H. D.; Kaya M.; Ucgun H.; Zeren M.; OKYALTIRIK F.; GÜRSES H. N.; OKYALTIRIK, FATMANUR; GÜRSES, HÜLYA NILGÜN